(1.24%) 5 126.93 points
(1.17%) 38 673 points
(1.98%) 16 155 points
(-0.75%) $78.36
(5.16%) $2.14
(-0.07%) $2 308.00
(-0.57%) $26.68
(0.32%) $965.65
(-0.32%) $0.929
(-1.11%) $10.87
(-0.07%) $0.797
(0.41%) $91.50
0.10% £ 501.00
Live Chart Being Loaded With Signals
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names...
Stats | |
---|---|
Tagesvolumen | 450.00 |
Durchschnittsvolumen | 3.85M |
Marktkapitalisierung | 3.69B |
EPS | £0 ( 2023-11-14 ) |
Last Dividend | £3.00 ( 2022-08-04 ) |
Next Dividend | £0 ( N/A ) |
P/E | 21.78 |
ATR14 | £1.585 (0.32%) |
Volumen Korrelation
Mediclinic International Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Mediclinic International Korrelation - Währung/Rohstoff
Mediclinic International Finanzdaten
Annual | 2022 |
Umsatz: | £3.23B |
Bruttogewinn: | £505.00M (15.62 %) |
EPS: | £0.210 |
FY | 2022 |
Umsatz: | £3.23B |
Bruttogewinn: | £505.00M (15.62 %) |
EPS: | £0.210 |
FY | 2021 |
Umsatz: | £3.00B |
Bruttogewinn: | £426.00M (14.22 %) |
EPS: | £0.0920 |
FY | 2020 |
Umsatz: | £3.08B |
Bruttogewinn: | £1.12B (36.43 %) |
EPS: | £-0.434 |
Financial Reports:
No articles found.
Mediclinic International Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£3.00 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £5.24 | 2016-06-16 |
Last Dividend | £3.00 | 2022-08-04 |
Next Dividend | £0 | N/A |
Payout Date | 2022-08-26 | |
Next Payout Date | N/A | |
# dividends | 9 | -- |
Total Paid Out | £35.14 | -- |
Avg. Dividend % Per Year | 0.19% | -- |
Score | 2.59 | -- |
Div. Sustainability Score | 8.34 | |
Div.Growth Potential Score | 4.50 | |
Div. Directional Score | 6.42 | -- |
Year | Amount | Yield |
---|---|---|
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £7.90 | 1.17% |
2019 | £7.90 | 2.50% |
2020 | £0 | 0.00% |
2021 | £0 | 0.00% |
2022 | £3.00 | 0.94% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SHED.L | Dividend Knight | 2023-06-29 | Semi-Annually | 9 | 2.67% | |
IHC.L | Dividend Junior | 2023-06-29 | Semi-Annually | 5 | 0.40% | |
BNKR.L | Dividend King | 2023-07-27 | Quarterly | 53 | 1.57% | |
YU.L | Dividend Junior | 2023-06-01 | Sporadic | 9 | 0.14% | |
NXT.L | Dividend Knight | 2023-07-06 | Annually | 32 | 1.71% | |
EPIC.L | Dividend King | 2023-09-14 | Monthly | 10 | 4.08% | |
SRP.L | Dividend Knight | 2023-09-07 | Annually | 32 | 0.97% | |
JIM.L | Dividend King | 2023-08-17 | Quarterly | 20 | 4.18% | |
CAM.L | Dividend Junior | 2023-09-14 | Annually | 32 | 1.66% | |
PRV.L | Dividend Knight | 2023-07-20 | Semi-Annually | 32 | 0.57% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0467 | 1.500 | 9.07 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0210 | 1.200 | 9.30 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0507 | 1.500 | -0.548 | -0.822 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.791 | 0.800 | 6.04 | 4.84 | [1 - 3] |
quickRatioTTM | 0.656 | 0.800 | -0.846 | -0.677 | [0.8 - 2.5] |
cashRatioTTM | 0.649 | 1.500 | 7.51 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.359 | -1.500 | 4.01 | -6.02 | [0 - 0.6] |
interestCoverageTTM | 4.52 | 1.000 | 9.44 | 9.44 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.751 | 2.00 | 9.75 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.509 | 2.00 | 9.75 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.833 | -1.500 | 6.67 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.156 | 1.000 | -0.730 | -0.730 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0866 | 1.000 | -0.268 | -0.268 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.214 | 1.000 | 9.92 | 9.92 | [0.2 - 2] |
assetTurnoverTTM | 0.449 | 0.800 | -0.343 | -0.274 | [0.5 - 2] |
Total Score | 8.34 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 24.46 | 1.000 | 7.63 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0507 | 2.50 | -0.352 | -0.822 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.509 | 2.00 | 9.83 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.751 | 2.00 | 9.75 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 19.07 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.171 | 1.000 | 8.22 | 0 | [0.1 - 0.5] |
Total Score | 4.50 |
Mediclinic International
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 453 theatres with approximately 11,538 inpatient beds in Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in the intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.